Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INDICIA: evolution of the initial distribution volume of glucose in severe burned adults
2024-513874-23-00Phase 2Authorised
- Sponsor
- CHR Metz-Thionville
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of glucose in burn injury, sponsored by CHR Metz-Thionville. Primary endpoint: Initial distribution volume of glucose (IDVG). Planned start Sep 2024; status: authorised.
02
Drugs
glucose
03
Conditions
burn injury
Beyond the preview
Go deeper on 2024-513874-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513874-23-00.